LIVE FEED — OCT 27, 2026
Aditya Rao
Contributor 168 stories

Aditya Rao

Senior Tech Correspondent at AI Data News, covering artificial intelligence, gadgets, and emerging technology trends across India and the globe. Passionate about making complex tech accessible to everyday readers, Aditya brings an authentic Indian tech-journalist perspective to every story.

FDA-Authorized AI That Reads Mammograms for Future Cancer Risk Goes Straight to Consumers Nationwide

FDA-Authorized AI That Reads Mammograms for Future Cancer Risk Goes Straight to Consumers Nationwide

Clairity Breast, an FDA-authorized AI tool that reads mammograms to predict five-year breast cancer risk, launched nationwide direct-to-consumer through Everlywell on October 1, 2026, bypassing the traditional physician-and-insurer pipeline. STAT News examined the move as part of its 'Paying for AI' series on the costs and tradeoffs of consumer-facing clinical AI.